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The IMP3 RNA-binding protein is associated with
metastasis and poor outcome in human cancer.
Using solid cancer transcriptome data, we found
that IMP3 correlates with HMGA2mRNA expression.
Cytoplasmic IMP3 granules contain HMGA2, and
IMP3 dose-dependently increases HMGA2 mRNA.
HMGA2 is regulated by let-7, and let-7 antagomiRs
make HMGA2 refractory to IMP3. Removal of let-7
target sites eliminates IMP3-dependent stabilization,
and IMP3-containing bodies are depleted of Ago1-4
and miRNAs. The relationship between Hmga2
mRNA and IMPs also exists in the developing limb
bud, where IMP1-deficient embryos show dose-
dependent Hmga2 mRNA downregulation. Finally,
IMP3 ribonucleoproteins (RNPs) contain other let-7
target mRNAs, including LIN28B, and a global gene
set enrichment analysis demonstrates that miRNA-
regulated transcripts in general are upregulated
following IMP3 induction. We conclude that IMP3
RNPs may function as cytoplasmic safe houses and
prevent miRNA-directed mRNA decay of oncogenes
during tumor progression.
INTRODUCTION
In principle, all posttranscriptional steps can have profound
effects on the expression of onco- and tumor-suppressor genes
and factors that maintain genome integrity. Although more than
500 different RNA-binding proteins participate in mRNA events,
only a handful of these proteins have been directly implicated in
neoplasia.
Insulin-like growth factor 2 (IGF2) mRNA-binding protein 3
(IMP3, IGF2BP3) belongs to a family of mRNA-binding proteins
(IMP1, IMP2, and IMP3) that are involved in RNA localization,
translation, and stability (Christiansen et al., 2009). IMP1 and
IMP3 form heterodimers and exhibit similar RNA-binding speci-
ficities (Nielsen et al., 2004). They are almost exclusively pro-
duced during embryogenesis with early maternal and zygoticexpression (for review, see Nielsen et al., 2001), followed by a
peak atmouse embryonic days 10.5–12.5 (E10.5–E12.5) (Nielsen
et al., 1999; Runge et al., 2000). IMPs aremainly cytoplasmic and
form large motile ribonucleoprotein (RNP) granules dispersed
around the nucleus and in cellular protrusions (Nielsen et al.,
2002). These RNP granules, or ‘‘locasomes,’’ are a unique RNP
entity distinct from neuronal hStaufen and/or fragile X mental
retardation protein granules, processing bodies (P bodies), and
stress granules (Jønson et al., 2007). Because granules contain
CBP80 and factors belonging to the exon-junction complex,
and lack eIF4E, eIF4G, and 60S ribosomal subunits, it is conceiv-
able that mRNAs in these bodies have never been translated.
IMP3 is found in a variety of cancers. IMP3-positive tumors
are prone to metastatic behavior and poor outcome (Beljan
Perak et al., 2012; Chen et al., 2011, 2013; Hoffmann et al.,
2008; Jeng et al., 2008; Jiang et al., 2008b; Kim et al., 2012;
Ko¨bel et al., 2009; Li et al., 2011; Lochhead et al., 2012; Lu
et al., 2011; Mentrikoski et al., 2009; Schaeffer et al., 2010; Sitni-
kova et al., 2008; Szarvas et al., 2012; Yantiss et al., 2008), and
IMP3 is widely used to depict metastatic tumor cells during
staging (Kapoor, 2008; Kim and Cha, 2011; Mentrikoski et al.,
2009; Mhawech-Fauceglia et al., 2010; Yantiss et al., 2008). In
support of a causal role in transformation, transgenic over-
expression of mouse IMP3/KOC leads to increased cell prolifer-
ation and metaplasia of pancreatic acinar cells (Wagner et al.,
2003), and in mammary-cancer-prone mice, overexpression of
IMP1 causes metastatic cancer (Tessier et al., 2004). Although
there is clear support for a direct role of IMP3 in tumorigenesis,
the mechanisms by which IMP3 elicits its effects are incom-
pletely understood.
To unravel the mechanism by which IMP3 promotes tumor
growth, we employed global transcriptome data from a large
set of solid cancers, and observed that IMP3 was correlated
with oncogenic HMGA2 mRNA expression. Similarly to IMP3,
HMGA2 is an oncofetal protein that is primarily expressed during
embryogenesis (Chiappetta et al., 1996; Zhou et al., 1995).
HMGA2 is tumorigenic and associated with poor prognosis
and low overall survival (reviewed in Fusco and Fedele, 2007).
TheHMGA2 30 UTR has considerable potential for posttranscrip-
tional regulation by RNA-binding proteins and miRNA-induced
silencing complexes (miRISCs) with its seven let-7miRNA target
sites in HMGA2 30 UTR (Lee and Dutta, 2007; Mayr et al., 2007).Cell Reports 7, 539–551, April 24, 2014 ª2014 The Authors 539
Figure 1. IMP3 in Human Carcinoma
(A) IMP3 mRNA expression in a series of 270 tumors from lung, kidney, colorectal, breast, and ovary cancers. The data were derived from the IMP3/IGF2BP3
203820_s_at probe set on the Affymetrix 133 Plus 2.0 arrays.
(B) The most enriched transcripts in IMP3-positive tumors as determined by a two-group comparison.
(C) Pearson correlation coefficient between IMP3 (203820_s_at probe set) and HMGA2 (208025_s_at probeset) in the different types of cancer, as well as the p
value, q value, and t value of the analysis.We show that IMP3 RNP granules contain large amounts
of HMGA2 transcripts, and that IMP3 locasomes protect and
upregulate HMGA2 by opposing the intersection between
Ago2/let-7 and HMGA2mRNA. IMP3 RNP granules also contain
a number of other let-7 target mRNAs, including the pluripotency
factor LIN28BmRNA, that promote tumor growth and embryonal
development by inhibiting let-7 biogenesis. A global gene set
enrichment analysis (GSEA) analysis demonstrated that the
protective role of IMP3 includes miRNA-regulated transcripts
in general. We propose that IMP3 locasomes may function as
cytoplasmic safe houses that prevent miRNA-directed mRNA
decay of proto-oncogenes during tumor progression and
embryogenesis.
RESULTS
IMP3 and HMGA2 mRNA Are Coexpressed in Human
Cancers
High levels of RNA-binding IMP3 have been associated with
poor outcome and metastasis in cancers of the lung, kidney,
colorectal, breast, and ovary (Beljan Perak et al., 2012; Bellezza
et al., 2009; Findeis-Hosey et al., 2010; Hoffmann et al., 2008;
Jiang et al., 2008a, 2008b; Ko¨bel et al., 2009; Lochhead et al.,
2012; Walter et al., 2009; Yuan et al., 2009). To identify putative
oncogenic mechanisms connected to IMP3, we examined IMP3
mRNA expression in a series of 270 tumors from the above
cancers and searched for transcripts that were correlated with
the presence of IMP3.
IMP3 was expressed at high levels in 45% of the tumors.
Compared with background in the negative tumors, IMP3 levels
were on average6.5-fold higher among positive tumors. Some
positive tumors exhibited an up to 40-fold increase in IMP3 (Fig-540 Cell Reports 7, 539–551, April 24, 2014 ª2014 The Authorsure 1A). To identify transcripts that were associated with IMP3
expression, we first employed a two-way comparison of IMP3-
positive tumors (>6 IMP3 log2 values) and IMP3-negative tumors
(<4.5 IMP3 log2 values) to depict enriched transcripts (Figure 1B).
We found that 163 transcripts were enriched in IMP3 tumors
after setting a p value cutoff at 1E-10 and a q value of 1E-10.
The most enriched transcript encoded HMGA2 (p = 1.9 3
1013), followed by ARNTL2, TOP2A, IGF2BP2 (IMP2),
SLC2A1, and MTHFD1L. The enrichment of IMP2 is in agree-
ment with the fact that HMGA2 promotes transcription of the
IMP2 gene (Brants et al., 2004; Li et al., 2012). A GSEA in
the molecular signatures database MSigDB (http://www.
broadinstitute.org) showed that IMP3-associated mRNAs over-
lapped with the Gene Ontology (GO) terms Cell_Cycle_Process
(p = 6 3 1013), Mitotic_Cell_Cycle (p = 8 3 1012), Spindle
(p = 13 1010), and Cell_Cycle_Phase (p = 63 1010), indicating
that IMP3-positive tumors, in agreement with previous reports,
were characterized by fast proliferation (Hartmann et al., 2012).
We subsequently examined a larger collection of 899 cancers
from the above groups and showed that the Pearson correlation
coefficient between IMP3 and HMGA2 among all groups was
0.44 with a false discovery rate (FDR) q value of 2.7 3 1050,
ranging from 0.12 in breast cancers to 0.5 in lung cancers
(Figure 1C). A closer analysis of the breast cancer group showed
that the lower correlation in these tumors could be explained
by the selective expression of IMP3 in triple-negative breast
cancers, whereas HMGA2 is also found in other histological
classes of breast tumors.
To substantiate the causal relation between IMP3 and
HMGA2, we generated a line of HT1080 cells expressing
3xFLAG-tagged IMP3 under control of a tetracycline-inducible
promoter, and immunoprecipitated IMP3 RNP after tetracycline
Table 1. List of the 20 Most Upregulated Transcripts after Induction of 3x-FLAG-IMP3
mRNA Reads
Median
Coverage RPKM
FC +tet
versus tet
FC IP(+tet)
versus CL(+tet)
No. of
Transcripts Let-7 SVR Scores let-7 Targetscan
IMP3* 2,729 34 20.9 16.1 1.1 – (1.1418) O (8-mer)
HMGA2 14,139 164 81.6 2.4 8.9 1,720.0 (0.3281, 0.9940, 0.2490,
0.8742, 0.1048)
O (8-mer)
IL1B 793 42 18.0 2.1 2.0 75.2 none
ANKRD46 377 6 3.1 2.1 1.2 – (0.2436) O (7-mer-m8)
BACH1 845 26 11.1 2.0 4.0 88.3 (0.5106, 1.0348) O (8-mer)
THBS1 11,330 151 68.4 1.9 1.2 – (0.1594) O (7-mer)
S1PR1 597 16 7.0 1.8 2.7 34.9 none
ZCCHC3 660 17 8.4 1.8 1.7 – (0.9080) O (7-mer-m8)
ITGB8 867 7 3.2 1.8 2.2 12.5 (0.1705) O (7-mer-m8)
ARL5B 480 9 4.6 1.8 4.1 33.5 none
ANKRD1 1,716 69 29.2 1.8 3.0 – none
PLAG1 447 4 2.0 1.8 4.7 16.2 none
SEMA3A 432 4 2.3 1.7 3.6 14.3 none
CPA4 2,491 62 29.0 1.7 2.0 95.7 (0.9174) O (8-mer)
TGM2 10,364 193 87.4 1.7 1.4 204.5 none
TNFRSF11B 332 11 4.5 1.7 1.4 10.6 none
LIN28B 334 4 1.9 1.7 2.5 8.1 (0.3931, 0.3511,
0.2389, 0.1497)
O (8-mer)
IRS2 865 13 7.1 1.6 1.3 – (0.3305) O (8-mer)
IL1RAP 650 7 3.5 1.6 1.6 9.0 none
C9orf6 793 33 14.3 1.6 9.0 208.2 none
Cultured cells were stimulated with vehicle or tetracycline for 24 hr before total RNA or IMP3 locasomes were isolated. Total RNA and transcripts asso-
ciated with the IMP3 RNP were subjected to RNA sequencing. The results represent three independent experiments. The table includes the fold
change after tetracycline-induction (FC +tet versus –tet) and the fraction of immunoprecipitated reads compared with the number in the initial cell-
lysate (FC IP(+tet) versus CL(+tet). Reads, coverage, and number of transcripts are also indicated. The putative let-7 target sites were identified by
submitting the gene symbols to the miRanda or Targetscan databases. The SVR scores of the individual elements are indicated.induction. Coimmunoprecipitated mRNAs were identified by
deep sequencing, and total RNA was also sequenced to deter-
mine the relative enrichment of transcripts in IMP3 RNP. A total
of 850 transcripts were enriched >3-fold compared with the
steady-state levels in HT1080 cells. HMGA2 was enriched 8.9-
fold, and in absolute numbers HMGA2 mRNA was the most
abundant transcript in IMP3 RNP (Table 1). Taken together,
these results demonstrate that IMP3 and HMGA2 mRNAs are
strongly correlated in solid cancers. Moreover, HMGA2 mRNA
is physically associated with IMP3 RNP in vivo.
IMP3 Upregulates HMGA2 mRNA and Protein
To further substantiate the causal relation between IMP3 and
HMGA2, we employed an additional stable HT1080 cell line
expressing FLAG-tagged HMGA2 protein. Whereas overexpres-
sion of FLAG-HMGA2 protein had no effect on the IMP3 level
(data not shown), induction of 3xFLAG-IMP3 (Figure 2A) was
followed by a time-dependent rise in the steady-state level of
endogenous 4.5 kb HMGA2 mRNA by a factor of 2.5 after
12 hr (Figure 2B). Similar results were obtained with 3xFLAG-
IMP1, which induced HMGA2 mRNA 3-fold after 24 hr (Fig-
ure S1). There was no indication of alternative HMGA2 mRNA
splicing or poly(A) site usage. Figure 2C summarizes the quanti-
fication of the data from the western and northern blot analyses.To examine whether the increased steady-state level of
HMGA2 mRNA was followed by an increased amount of
HMGA2 protein, we performed a western blot analysis in the
absence or presence of tetracycline (Figure 2D). Corresponding
to the increase in HMGA2 mRNA, HMGA2 protein levels
increased 2.1-fold. Mixing uninduced and tetracycline-induced
cells followed by immunocytochemical staining of either nuclear
HMGA2 protein (green color) or cytoplasmic 3xFLAG-IMP3 (red
color, Figures 2E and 2F) showed that nuclear HMGA2 staining,
quantified by confocal microscopy, also was 2-fold higher in
tetracycline-induced cells.
Finally, we determined the translational status of HMGA2
mRNA following IMP3 induction by means of polysome isolation
(Figures 3A and 3B). The analysis provided no indications of
altered translational initiation in the presence of IMP3, since
HMGA2 4.5 kb mRNA sedimented in polysomal fractions 4–8
regardless of tetracycline addition. 3xFLAG-IMP3 was mainly
located in subpolysomal fractions 3–5 (Figure 3C).
IMP3 Precludes the HMGA2 and Ago2/let-7 Intersection
HMGA2 mRNA comprises seven putative let-7 target sites in
the 30 UTR, and regulation of HMGA2 mRNA decay provides a
paradigm for let-7-dependent inactivation via the RISC pathway
(Boyerinas et al., 2008; Lee and Dutta, 2007; Mayr et al., 2007;Cell Reports 7, 539–551, April 24, 2014 ª2014 The Authors 541
Figure 2. IMP3 Upregulates HMGA2 mRNA and Protein
(A and B) Time course of steady-state IMP3 protein (A) and HMGA2mRNA (B) levels after addition of tetracycline in TREX1080 cells stably expressing 3xFLAG-
IMP3. The full-length HMGA2 transcript of 4.5 kb migrates at the front of the 28S rRNA.
(C) Quantification of the IMP3 protein and the HMGA2mRNA content observed after induction of 3xFLAG-IMP3 expression. GAPDH protein andGAPDHmRNA
content were included as controls in the western blot and northern blot analyses, respectively.
(D) Western blot analysis of IMP3, HMGA2, and GAPDH from TREX1080 3xFLAG-IMP3 cells in the absence (left track) or presence (right track) of tetracycline for
24 hr. The fold change of the protein levels is indicated.
(E) Immunocytochemistry of TREX1080 3xFLAG-IMP3 cells. Tetracycline-stimulated and nonstimulated TREX1080 3xFLAG-IMP3 cells were mixed and plated in
a glass bottom dish for 4 hr before they were fixed and stained using FLAG (red) and HMGA2 (green) antibodies. The bottom-right panel depicts the overlay and
the bottom-left panel shows the Nomarski rendering. Nonstimulated cells are indicated with asterisks.
(F) Quantification of the nuclear HMGA2 staining in themixture of cells described in (E). Ten images were processed with the same settings (pinhole, amplification,
and exposure time). The cells were depicted as 3xFLAG-IMP3-expressing cells when the red fluorescent signal intensity was >100 arbitrary units. Cells with a red
fluorescent signal between 0 and 100were classified as cells with a leaky tetracycline repressor activity (<5%of themeasured cells). The red and green intensities
from 80 cells are included in the graph. The error bars represent the SD, and *** represents a p value < 0.0001 using an unpaired Student’s t test.Park et al., 2007). Consequently, we considered whether IMP3
would oppose the actions of let-7 miRNA on HMGA2 mRNA.
Segmentation of HMGA2 mRNA and UV crosslinking with
recombinant IMP3 or lysates from uninduced or tetracycline-
induced TREX1080 cells initially showed that IMP3 exhibited
strong binding to the HMGA2 30 UTR (Figure S2). Endogenous542 Cell Reports 7, 539–551, April 24, 2014 ª2014 The Authorslet-7 isoforms in HT1080 cells were inhibited by a locked nucleic
acid (LNA) antagomiR directed toward the let-7 family in the
absence or presence of tetracycline (Figure 4A). A mock
transfection or transfection with the unrelated antagomiR anti-
miR-449b gave similar results in terms of elevated HMGA2
mRNA expression following 3xFLAG-IMP3 induction. In
Figure 3. Translation of Endogenous HMGA2 mRNA following
3xFLAG-IMP3 Induction
(A) A260 profiles of polysomes isolated from exponentially growing TREX1080
cells in the absence or presence of tetracycline.
(B) Northern blot analysis of HMGA2mRNA or 18S rRNA in total RNA isolated
from the sucrose gradient fractions. Photon-stimulated luminescence (PSL)
minus background (BG) for total HMGA2 mRNA = 34,598 and 76,346 in the
absence or presence of tetracycline, respectively. The corresponding PSL 
BG numbers are 1,039,856 and 797,279 for the 18S rRNA signal.
(C) Western blot analysis of IMP3 in the sucrose gradient fractions.contrast, 3xFLAG-IMP3 was unable to increase the level of
endogenous HMGA2 mRNA beyond the level achieved by
removing the let-7 family, in agreement with a model in which
IMP3 increases HMGA2 expression by opposing let-7-mediated
decay.
To examine whether the observed effects on the endogenous
transcript could be recapitulated in an artificial reporter system
with mutated target sites (Figures 4B and 4C), we inserted
let-7 2&3 and 6&7 target sites into a luciferase reporter vector.
Mutating both target sites in the segment with sites 2&3 abol-
ished the effect of 3xFLAG-IMP3, and mutating a single target
site in the 6&7 segment was sufficient to eliminate the effect of
3xFLAG-IMP3. In contrast, wild-type versions of segments 2&3and 6&7 exhibited increased firefly activity upon 3xFLAG-IMP3
induction. We observed a nonadditive effect of 3xFLAG-IMP3
induction both on endogenous HMGA2 mRNA employing a
let-7 antagomiR and on a luciferase reporter containing mutated
let-7 target sites, implying that IMP3 protects HMGA2 mRNA
from the RISC pathway.
To corroborate the functional significance of IMP3-dependent
let-7 interference, we examined the proliferative capacity of
3xFLAG-IMP3 in the absence or presence of the let-7 family
antagomiR. As shown in Figure 4D, the number of cells that
overexpressed IMP3 began to increase 10–12 hr following the
addition of tetracycline. This coincided with the increase of the
HMGA2 transcript, which was visible after 6 hr of tetracycline
treatment and continued to increase for an additional 10 hr (Fig-
ures 2B and 2C). The effect of 3xFLAG-IMP3 expression on the
doubling time was similar to that observed after addition of the
let-7 family antagomiR, and the two treatments were not
additive. The reduction in doubling time upon 3xFLAG-IMP3
addition is 13%, which will generate a 74-fold difference in tumor
volume after 1 month (720 hr). Knockdown of HMGA2 mRNA
was followed by a clear inhibition of cell proliferation and elimi-
nated the effect of IMP3 (Figure 4E).
IMP3 Locasomes Provide a RISC-Free Cytoplasmic
Repository for HMGA2 mRNA
Because the luciferase reporter assay of HMGA2 30 UTR
segment 2&3 in Figures 4B and 4C showed that downregulation
of luciferase expression by let-7 miRNA could be partially
rescued by IMP3, we examined the possibility of a direct compe-
tition between let-7g miRNA and IMP3 for the HMGA2 segment
2&3 (30 UTR positions 1,088–1,306). The electrophoretic
mobility-shift analysis shown in Figure 5A indicates that recom-
binant IMP3 is able to associate with radiolabeled segment
2&3 with a Kd of 1 nM, and the analysis in Figure 5B reveals
that radiolabeled let-7gmiRNA is able to associate with its target
RNA in segment 2&3, regardless of the presence of IMP3. To
pinpoint the interactions between the three species at the nucle-
otide level, we carried out a selective 20-hydroxyl acylation
analyzed by primer extension (SHAPE) analysis of segment
2&3 RNA (McGinnis et al., 2012). Figure 5C shows that in the
presence of IMP3 alone, acylations are enhanced in the seed
target region, whereas in the presence of let-7g miRNA, acyla-
tions are blocked due to duplex formation between the let-7g
seed region and its target, regardless of the presence of IMP3.
In contrast, outside the seed target region in segment 2&3, the
acylation behavior is dictated by IMP3 rather than let-7g miRNA.
We infer that IMP3 and let-7gmiRNA are able to associate simul-
taneously with HMGA2 segment 2&3 in vitro, so the opposing
effect observed in vivo is unlikely to result from a straightforward
competition between let-7g miRNA and IMP3 for the HMGA2 30
UTR seed target.
Because upregulation of HMGA2mRNA was unlikely to result
from a direct sterical hindrance of let-7 miRNA binding, we
examined whether IMP3 RNP represents a RISC-free environ-
ment. Immunoprecipitations of cytoplasmic lysates in the pres-
ence of 0.5 mM EDTA with Ago2 or FLAG antibodies (Figure 6A)
revealed that endogenous full-length HMGA2 mRNA was
virtually undetectable in the anti-Ago2 immunoprecitate. TheCell Reports 7, 539–551, April 24, 2014 ª2014 The Authors 543
Figure 4. IMP3-Induced Increase of HMGA2 mRNA Depends on let-7 miRNA
(A) Endogenous HMGA2 mRNA levels after 3xFLAG-IMP3 induction in the presence of mock, anti-miR-449b, or anti-let-7 LNA antagomiR. The LNA miCurry
inhibitors were transfected 16 hr before the cells were split and cultured in media with or without tetracycline. The data represent three independent experiments
and are presented as mean ± SD.
(B) Schematic representation of full-length HMGA2mRNA and the firefly luciferase reporter constructs encompassing two let-7 target sites 2&3 (green) and 6&7
(blue) examined in the absence or presence of 3xFLAG-IMP3. Colored boxes depict reading frames, UTRs are depicted as gray lines, and 2&3 and 6&7 designate
RNA segments that exhibit strong IMP3 binding. In addition to the two wild-type segments inserted downstream of firefly luciferase, two other constructs were
made in which two nucleotides in the seed target sequence (UACCUC/UGCGUC) were mutated.
(C) Activation of the luciferase reporters outlined in (B) by 3xFLAG-IMP3 in the presence of intact or mutated let-7 target sequences. The y axis represents the
relative firefly luciferase activity divided by the Renilla luciferase activity. In the segment 2&3 construct, both let-7 target sites were mutated (HMGA2 Seg 2 m&3
m), whereas only the biologically active target site was mutated in the segment 6&7 construct (HMGA2 Seg 6 m&7). The data originate from three independent
experiments and are presented as the mean ± SD.
(legend continued on next page)
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Figure 5. IMP3 and let-7gmiRNA Associate Simultaneously with an
HMGA2 30 UTR Segment Encompassing Target Site 3 In Vitro
(A) Electrophoretic mobility shift assay of 32P-labeled 30 UTR segment 2&3
(positions 1,088–1,306) with increasing concentrations of recombinant IMP3.
(B) Electrophoretic mobility shift assay of 50[32P]-let-7g miRNA with recombi-
nant IMP3, unlabeled 30 UTR segment containing target site segment 2&3, or a
combination of IMP3 and the 30 UTR segment.H19 is a similar-sized unlabeled
RNA that exhibits IMP3 attachment.
(C) SHAPE analysis of a 30 UTR segment containing target site 2&3 on its own,
in combination with either IMP3 or let-7g, or in the presence of both. U, A, G,
and C designate dideoxynucleoside sequencing tracks, and the middle four
tracks derive from samples that have not been exposed to the 1M7 reagent.
The vertical bar brackets the positions complementary to 2–8 in let-7 miRNA.
The SNP rs1042725 is the C/T polymorphism associated with height in GWA
studies.abundance of let-7 miRNAs implied an intact RISC particle, at
least in terms of the interaction between Ago2 and miRNA. In
contrast, the full-length HMGA2 mRNA was abundantly present
in the 3xFLAG-IMP3 immunoprecipitate, even to the extent that it
was visually diminished in the nonbound material. Moreover, the
absence of Ago2 in the anti-FLAG immunoprecipitate (and vice(D) Removal of let-7 opposes the mitogenic actions of IMP3. TREX1080 cells stab
the let-7 miRNA family and a mock control. Half of the transfected cells were
expression, followed by seeding in E-plates (Roche) andmeasurement of cell grow
at 0 hr to normalize for differences in plating. The data represent three independ
(E) HMGA2 is essential for cell proliferation. TREX1080 cells stably expressing
HMGA2 and a control siRNA. After transfection, cells were grown in the absence
seeding in E-plates (Roche) and measurement of cell growth in an xCELLigence a
differences in plating. The data represent three independentmeasurements and a
18S rRNA content was performed after siRNA transfection and visualized by gelversa) shows that RISC particles and IMP3 RNPs are distinct
entities with little overlap from a biochemical point of view.
Finally, as described above, eIF4E was absent from IMP3
RNP. To corroborate the biochemical observations, we per-
formed immunocytochemistry with iMP3, Ago2, and DCP1a an-
tibodies (with the latter staining P bodies). Confocal microscopy
showed that there was no overlap between anti-iMP3 and either
anti-Ago2 or anti-DCP1a stainings, reinforcing the biochemical
observations (Figure 6B). Similar results were obtained following
analysis of Ago1, Ago3, and Ago4 with respect to both coimmu-
noprecipitation and cellular distribution (Figure S3). Moreover,
we examined the presence of miRNAs in RNA from total lysates
or 3xFLAG-IMP3 and 3xFLAG-RRM1-2 (negative control) immu-
noprecipitates by global miRNA microarray analysis (Figure S4).
This demonstrated that miRNAs were excluded from the IMP3
granules. No statistical difference was observed between IMP3
and RRM1-2 isolates (FDR > 0.2). Taken together, these data
imply that IMP3 RNPs provide a cytoplasmic domain that is
devoid of components of the RISC pathway.
Let-7 Targets in IMP3 RNP Granules
IMP3 locasomes have been proposed to represent posttran-
scriptional regulons (Jønson et al., 2011). To generalize our
observations concerning IMP3 and miRNA activity, and reveal
additional transcripts that could play a role in cancer progres-
sion, we compared global RNA sequencing profiles from cells
treated with and without tetracycline with the transcripts identi-
fied in the particles. Among the 20 most upregulated transcripts,
eight of 19 (excluding IMP3) exhibited let-7 seed target
sequences according to the miRanda database, and nine of 19
exhibited them when we employed Targetscan to predict the
targets. As shown in Table 1, the HMGA2 transcript was the
most upregulated transcript (2.4-fold) upon IMP3 induction, fol-
lowed by ANKRD46, BACH1, THBS1, ZCCHC3, ITGB8, CPA4,
IRS2, and LIN28B. HMGA2 was strongly enriched (9-fold) in
the particles together with let-7 target-containing BACH1,
ITGB8, CPA4, and LIN28B. A number of the remaining enriched
transcripts were targets for other miRNAs, in particular
miR-181a/b (data not shown).
RNA-binding LIN28B blocks the nuclear conversion of the
primary let-7 transcript to pre-let-7 (Heo et al., 2008; Viswana-
than et al., 2008), and LIN28B promotes malignant growth by
opposing let-7 (Viswanathan et al., 2009). Moreover, LIN28B is
expressed at the same developmental stages as IMPs (Yang
and Moss, 2003) and controls body size similarly to HMGA2
and IMP1 (Shinoda et al., 2013). Therefore, we considered
whether IMP3 locasomes represent a regulon that integrates
the expression of LIN28B and HMGA2 by opposing let-7. Wely expressing 3xFLAG-IMP3 were transfected with an LNA antagomiR against
grown in the absence or presence of tetracycline to induce 3xFLAG-IMP3
th in an xCELLigence apparatus. The number of cells was set to one (cell index)
ent measurements and are presented as mean ± SD.
3xFLAG-IMP3 were transfected with a small interfering RNA (siRNA) against
or presence of tetracycline to induce 3xFLAG-IMP3 expression, followed by
pparatus. The number of cells was set to one (cell index) at 0 hr to normalize for
re presented asmean ±SD. Quantitative PCR of the cellularHMGA2mRNA and
electrophoresis.
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Figure 6. IMP3 Locasomes Are RISC-Free Repositories for HMGA2 mRNA
(A) TREX1080 cells stably expressing 3xFLAG-IMP3 were lysed and aliquoted for subsequent immunoprecipitations with antibodies against Ago2 or the FLAG-
tag. Total cell lysate (CL) and proteins that were not bound to the beads (NB) or immunoprecipitated proteins (IP) were analyzed by western blot analysis (upper
three panels) with the indicated antibodies against Ago2, IMP3, or eIF4E. Negative controls () depicted in tracks 4 and 7 show the result from protein-G-coated
beads without a conjugated antibody. Northern blot analyses using probes against the open reading frame of HMGA2 mRNA, let-7 miRNAs, or 5S rRNA are
shown in the bottom three panels. The immunoprecipitated material corresponded to 32 times the input.
(B) Immunocytochemical analysis of IMP3 locasomes and P bodies. Cells were cultured in glass-bottom dishes, fixed, and incubated with anti-Ago2 (panels 2,
4, and 5), anti-DCP1a (panels 7 and 10) and anti-FLAG (panels 3, 4, 6, 8, and 10) antibodies, and secondary antibodies before they were examined by
confocal microscopy. Nomarski pictures are included to provide an overview of the cells. Blowouts are marked by the square and arrow, and are depicted in
panels 5 and 6.examined the effect of IMP3 and let-7 antagomiRs on LIN28B
mRNA expression (Figure S5), and found that similarly to
HMGA2 mRNA, LIN28B mRNA was induced 2-fold after
3xFLAG-IMP3 induction. Let-7 antagomiRs increased the
steady-state level of LIN28B mRNA 3-fold, and it was not
possible to impose a further increase of the LIN28B transcript
following addition of 3xFLAG-IMP3. MiR-449, which was
included as a control, had no effect on the LIN28B mRNA level.
For comparison, we also examined the effects of 3xFLAG-IMP3
and let-7 antagomiRs on IMP1 expression. IMP1mRNA exhibits546 Cell Reports 7, 539–551, April 24, 2014 ª2014 The Authorslet-7 target sites in the 30 UTR (Boyerinas et al., 2008), but in
contrast to HMGA2 and LIN28B mRNAs, the transcript is not
associated with IMP3 RNP. In agreement with a protective activ-
ity of granule association, IMP1 mRNA was not increased upon
induction of 3xFLAG-IMP3, whereas addition of let-7 antago-
miRs increased the level of IMP1 transcripts.
To examine whether IMP granules exhibit a more generalized
protection of miRNA-targeted mRNAs, we generated a list of
miRNA-regulated mRNAs by combining Targetscan predictions
with the expression of miRNAs and mRNAs as described
previously (Gallagher et al., 2010). To validate the list of putative
miRNA targets, we first performed a GSEA with the 1,000
transcripts that were predicted to be most repressed in
HEK293 cells in a previous Ago2 knockdown analysis from
Schmitter et al (2006) (Figure S6A). This showed that the
predicted miRNA-regulated transcripts were clearly enriched
following Ago2 knockdown.
To study whether IMP1 or IMP3 imposed a global protection
against miRNAs, we performed GSEAs using the top 300
miRNA-regulated mRNAs in the two-group comparisons of
tetracycline-induced 3xFLAG-IMP1 HT1080 cells (Figure S6B),
3xFLAG-IMP3 HT1080 cells (Figure S6C), and 3xFLAG-IMP1
HEK293 cells (Figure S6D) versus noninduced cells. In all cases,
we observed a significant (p < 0.001) enrichment of the miRNA-
repressed mRNAs following IMP overexpression. As expected,
not every miRNA-targeted transcript became upregulated,
conceivably because IMPs bind different mRNAs with varying
affinity. We therefore examined whether transcripts that were
highly embedded in the granules would be insensitive to Ago2
knockdown compared with transcripts in which only a small
fraction of the total pool was bound to IMP granules. The analysis
showed that tightly associated mRNAs were unresponsive
to Ago2 knockdown (NES = 0.92, p = 0.549) (Figure S6F),
whereas less-granule-associated mRNAs were enriched
following Ago2 depletion (NES = 1.42, p = 0.002) (Figure S6E),
in agreement with a model in which granule-associated mRNAs,
in general, are less accessible to the RISC complex. Taken
together, these results indicate that IMP1 and IMP3 granules
provide a generalized protection against miRNA-mediated
mRNA decay.
Interplay among Hmga2 mRNA, let-7 miRNA, and IMP1
during Limb Bud Development
To establish whether the effects observed in HT1080 cells also
occurred in the intact organism, we directed our attention toward
the developing mouse. Figure 7A is a schematic outline of the
reciprocal expression of Hmga2 mRNA and let-7 miRNA during
mouse development (Park et al., 2007) upon which the narrow
temporal expression of the IMP family has been superimposed
(Nielsen et al., 1999). Characteristically, IMPs are present at
the stage where there is a sharp posttranscriptional downregula-
tion of Hmga2 mRNA mediated by increasing amounts of let-7
miRNA. Therefore, it ought to be feasible for IMPs to adjust the
expression of Hmga2, provided a similar spatial expression
pattern is observed.
IMP1 and IMP3 exhibited similar binding to HMGA2 segment
2&3 and segment 6&7 (Figure 7B), and, as described above,
both factors induced HMGA2 to the same extent (Figure S1).
We employed Imp1 mice because IMP1 is the dominant fetal
isoform, whereas IMP3 is predominantly expressed during carci-
nogenesis. In situ hybridizations with either an Imp1 probe (Fig-
ure 7C, pictures 1 and 2) or an Hmga2 probe (Figure 7C, pictures
3 and 4) at E12.5 showed overlapping staining with both probes
in the limb bud. Therefore, limb buds from wild-type Imp1, het-
erozygous Imp1/, and knockout / mice were examined at
E13.5 and E14.5 to achieve different concentrations of IMP1
protein. In parallel, quantification of a northern blot analysis of
full-length Hmga2mRNA revealed that there was a dose-depen-dent decrease in the Hmga2 mRNA level upon IMP1 depletion
(Figures 7D and 7E). We infer that the interplay between
HMGA2 mRNA and the IMP RNA-binding protein family, as
seen in a human cancer cell line, is also present in the developing
limb bud in the mouse.
DISCUSSION
To search for molecular targets of IMP3, we employed a large
number of genome-wide expression profiles from different solid
tumors and searched for mRNAs that were correlated with IMP3
expression. This approach is appealing because it requires no a
priori assumption of possible interactions. Moreover, the data
reflect the situation in real solid tumors.We discovered a positive
association between HMGA2 and IMP3, which we examined
further because HMGA2 is a well-established oncogene and
overlaps temporally and spatially with IMP3 during embryogen-
esis (Cleynen and Van de Ven, 2008).
IMP3 was physically associated with and upregulatedHMGA2
mRNA and protein, with no apparent effect on translation initia-
tion. Since IMP3 resides in stable cytoplasmic RNP granules, it
was conceivable that IMP3 stabilized HMGA2 mRNA. This let
us to examine the effect of IMP3 on let-7-dependent downregu-
lation of HMGA2 mRNA. Although RNA-binding proteins such
as IMPs may affect miRNA binding (Elcheva et al., 2009) and
miRNA biogenesis, or alter the secondary structure of miRNA
target sites (reviewed in van Kouwenhove et al., 2011), we
were unable to reveal a straightforward competition between
IMP3 and let-7 for a common cis element. Instead, our results
point toward an additional possibility that has implications for
our understanding of mRNA locasomes/granules. Both the
immunoprecipitation and colocalization experiments showed
little, if any, overlap between IMP3 and Ago2, which is compat-
ible with distinct cytoplasmic domains for IMP3 and Ago2. In
this way, IMP3 locasomes may be regarded as safe houses for
mRNAs, where they are protected from degradation on the
way to their final destinations and translation. As mentioned
above, transcripts have not completed their pioneering round
of translation, so it is appealing to regard locasomes as an exten-
sion of the nuclear compartment in the cytoplasm.
The physical details of IMP granules, and RNP granules in
general, are beginning to emerge. Recent studies of synaptic
RNP granules have shown that they exit the nucleus by budding
through the inner and outer membranes via a nuclear egress
mechanism (Speese et al., 2012). Aggregation and recruitment
into condensed hydrogels are likely to occur through polymeriza-
tion of low-complexity sequences present in RNA-binding pro-
teins (Han et al., 2012; Kato et al., 2012). In agreement with these
observations, IMP granules are dynamic and exhibit a diameter
in the range of 100–300 nm. Particles may contain several hun-
dred protein molecules roughly the size of IMPs and 10–30
mRNA transcripts (Jønson et al., 2007), and their ‘‘nuclear’’ sta-
tus is supported by the presence of PABN1/PABP-2 (Speese
et al., 2012). It remains to be resolved how Ago2/RISC is
excluded from the locasomes, but a combination of sterical hin-
drance by the dense protein core and a lack of low-complexity
sequences that are required for sustained association with the
particles (Weber and Brangwynne, 2012) may play a role.Cell Reports 7, 539–551, April 24, 2014 ª2014 The Authors 547
Figure 7. The Mouse Hmga2 mRNA Level Correlates with IMP1 Protein Expression during Limb Bud Development
(A) Schematic outline of the Imp1/3, Hmga2, and let-7 RNA levels during mouse development.
(B) Electrophoretic mobility shift analysis of 30 UTR segments 2&3 and 6&7 with recombinant IMP1 and IMP3.
(C) Whole-mount in situ hybridizations with DIG-labeled Imp1 probes (panels 1 and 2) and Hmga2 probes (panels 3 and 4).
(D) Northern blot analysis of total RNA isolated from limb buds of a wild-type mouse embryo, a heterozygotic Imp1/ embryo, and an Imp1 knockout embryo at
E13.5 and E14.5. The PSL is indicated below.
(E) Western blot analysis shows the IMP1 and GAPDH protein levels within the limb buds used for the northern blot analysis.Several transcripts in the locasomes contained let-7 target
sites (Dogar et al., 2014; Hu et al., 2013; Yun et al., 2011; Zhu
et al., 2011) and became upregulated upon IMP3 induction.
One of these was LIN28B mRNA, which, similarly to IMP3 and
HMGA2, has been implicated in various developmental pro-
cesses and cancer (reviewed by (Thornton and Gregory, 2012).
LIN28B blocks the production of mature let-7 miRNA (Heo
et al., 2008; Viswanathan et al., 2008), and this promotes malig-
nant growth (Molenaar et al., 2012; Viswanathan et al., 2009). In
humans and mice, IMP3/IMP1, HMGA2, and LIN28B are
involved in growth and differentiation, and the deletion of either
factor in mice leads to dwarfism (Hansen et al., 2004; Shinoda548 Cell Reports 7, 539–551, April 24, 2014 ª2014 The Authorset al., 2013; Zhou et al., 1995). The physiological significance
of the intersection is illustrated by the lowered Hmga2 mRNA
levels in the E13.5 limb buds of our Imp1 knockout mice, which
emphasizes the critical importance of RNA-binding protein
concentration in the intact organism. LIN28B mRNA is coex-
pressed with members of the IMP family during midgestation,
particularly in epithelia (Yang and Moss, 2003), and LIN28B
mRNA is also coexpressed with IMP3 mRNA in a number of
cancers (data not shown). Therefore, taken together, our findings
indicate that the activity of HMGA2, LIN28B, and let-7 is co-
ordinated by heterochronic IMP3 during embryogenesis and
carcinogenesis.
Taken together, the IMP3-mediated alleviation of let-7 activity
toward HMGA2 and LIN28B mRNAs may explain why poor
outcome is a hallmark of IMP3-positive tumors. Moreover, our
data demonstrate how posttranscriptional mechanisms may be
deeply involved in tumor progression, and we propose that
segregation of transcripts into IMP3 RNPs may be a general
mechanism that prevents miRNA-dependent mRNA decay
during tumor growth.
EXPERIMENTAL PROCEDURES
Tumor Gene-Expression Profiles
Expression profiles of tumor samples were downloaded from the Gene
Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) or generated
from samples collected and processed at our own facility at Rigshospitalet.
All tumors were analyzed on human U133 Plus 2.0 arrays (Affymetrix). Cell files
were preprocessed using the robust multichip average (RMA) method (Bolstad
et al., 2003) and evaluated for quality parameters using the Simpleaffy func-
tionality of the R/Bioconductor packages. The data were visualized and
analyzed using the Qlucore Omics Explorer software, and the probe sets
employed in the two-way comparison and Pearson correlation coefficient
were IMP3 (203820_s_at) and HMGA2 (208025_s_at).
Inhibition of let-7 Family Members
Amixture of LNA antagomiRs was produced to specifically inhibit all members
of the let-7 family of miRNAs. The mixture consisted of five custom-designed
LNA-containing oligonucleotides (hsa-let-7a-d CAACCTACTACCTC, hsa-
let-7e ACAACCTCCTACCTC, hsa-let-7f ACAATCTACTACCTC, hsa-let-7g-i
ACAAACTACTACCTCA, and hsa-miR-98 CAACTTACTACCTCA). Upon
transfection of the let-7 family inhibitor mixture (50 nM) into TREX1080
3xFLAG-IMP3 cells, tetracycline was added to induce transcription of the
3xFLAG-IMP3 construct. As control, an LNA inhibitor against miR-449b was
used (CCAGCTAACAATACACTGCCT). Transfections were performed with
Turbofect (Fermentas). Cells were harvested 24 hr after transfection and sub-
sequently lysed in TriZol (Invitrogen).
Isolation of 3xFLAG-IMP3 and Ago2 RNPs
Anti-Ago2 agarose beads were prepared with protein A/G and the 4F11 Ago2
antibody (Ru¨del et al., 2008), and immunoprecipitation of 3xFLAG-IMP3 was
performed as previously described using anti-FLAG agarose beads from
Sigma-Aldrich (Jønson et al., 2011).
SHAPE Probing
For SHAPE probing, 10 nM ofHMGA2 30 UTR segment 1,088–1,306 was rena-
tured in 20 mM Tris-HCl, pH 7.8, 140 mM KCl, 2 mM MgCl2, and 0.1% Triton
X-100 by heating at 90C for 1min and at 56C for 10min, followed by the addi-
tion of 0.4 U/ml RNasin and 2 mM dithiothreitol. Binding of 30 nM recombinant
IMP3 to renatured RNA was carried out at 30C for 20 min, and 30 nM let-7g
miRNA was subsequently added for 10 min. The acylation reaction by 8 mM
1-methyl-7-nitroisatoic anhydride (1M7) proceeded for 70 s at room tempera-
ture, and the reaction was stopped by the addition of water. Analysis of acyl-
ation reactions and dideoxynucleoside sequencing tracks were obtained by
reverse transcription initiated by a 50 end-labeled primer complementary to
HMGA2 30 UTR positions 1,283–1,306 as described previously (Nielsen and
Christiansen, 1992).
Whole-Mount RNA In Situ Hybridization
Whole-mount RNA in situ hybridization was performed as previously
described (Hansen et al., 2004). In brief, embryos were fixed overnight in 4%
paraformaldehyde at 4C. After three washes in PBT (PBS plus 1% Tween
20), the embryos were rehydrated in a series of methanol-PBT, bleached in
6% hydrogen peroxide, and treated with proteinase K (Roche). The embryos
were prehybridized in hybridization buffer containing yeast tRNA and hybrid-
ized at 65C overnight in hybridization buffer containing 1 mg/ml of Hmga2
or Imp1 digoxigenin-labeled antisense riboprobe. After hybridization, theembryos were washed in RNaseA-containing wash buffer. The transcripts
were detected by overnight incubation with digoxigenin antibody (Roche).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.03.015.
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